What's in Muhammad Aamir Latif's pipeline?

Muhammad Aamir Latif has 10 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 6 in Phase 1.

Which companies overlap with Muhammad Aamir Latif's portfolio?

Top competitors by shared drug class: Sanofi, BioBalance Corporation, Chuncheon Sacred Heart Hospital, CD Pharma India Pvt. Ltd., CHU de Quebec-Universite Laval.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/muhammad-aamir-latif.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Muhammad Aamir Latif — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Muhammad Aamir Latif pipeline: 1 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 1 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Terbutaline Infusion	Terbutaline Infusion	marketed	Beta-2 adrenergic agonist (short-acting)	Beta-2 adrenergic receptor (ADRB2)	Respiratory
S. boulardii	S. boulardii	phase 3	Probiotic		Gastrointestinal
Supportive care	Supportive care	phase 3			Oncology

Therapeutic area mix

Gastrointestinal · 1
Oncology · 1
Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Sanofi · 2 shared drug classes
BioBalance Corporation · 1 shared drug class
Chuncheon Sacred Heart Hospital · 1 shared drug class
CD Pharma India Pvt. Ltd. · 1 shared drug class
CHU de Quebec-Universite Laval · 1 shared drug class
Children's Hospital of Philadelphia · 1 shared drug class
Biocodex · 1 shared drug class
Amphastar Pharmaceuticals, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Muhammad Aamir Latif:

Cite this brief

Drug Landscape (2026). Muhammad Aamir Latif — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/muhammad-aamir-latif. Accessed 2026-05-16.